http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2009142086-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2009-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2009142086-A1 |
| titleOfInvention | Vaccine composition for mycoplasma infection |
| abstract | The present invention provides an antigen that contributes to the development of a safe and effective vaccine against mycoplasma pneumonia that does not currently have effective preventive measures, and a vaccine that uses the antigen. Specifically, a peptide designed from a lipoprotein derived from Mycoplasma pneumoniae, a vaccine composition containing the peptide and a pharmaceutically acceptable carrier, and an antibody that recognizes the peptide as an epitope are effective. A prophylactic or therapeutic agent for mycoplasma infection contained as a component is provided. |
| priorityDate | 2008-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.